<?xml version="1.0" encoding="UTF-8"?>
<notes>
 <title>Funding</title>
 <p>H.A. was supported by the Alfried Krupp von Bohlen und Halbach Foundation, Essen; the Deutsche Krebshilfe, Bonn (70112168); the Deutsche Forschungsgemeinschaft (DFG, grant number AL 465/9-1); the HEiKA Initiative (Karlsruhe Institute of Technology/University of Heidelberg collaborative effort); the DKFZ-MOST Cooperation, Heidelberg (grant number CA149); the HIPO/POP-Initiative for Personalized Oncology, Heidelberg (H032 and H027). S.V. and M.B. were supported by a grant from the Else-Uebelmesser-Stiftung (grant no. D.30.21947) and PASCOE Pharmazeutische Praeparate GmbH. We further acknowledge support by Open Access Publishing Fund of University of Tuebingen.</p>
</notes>
